Search for other papers by Nella Augusta Greggio in
Google Scholar
PubMed
Search for other papers by Elisa Rossi in
Google Scholar
PubMed
Search for other papers by Silvia Calabria in
Google Scholar
PubMed
Search for other papers by Alice Meneghin in
Google Scholar
PubMed
Search for other papers by Joaquin Gutierrez de Rubalcava in
Google Scholar
PubMed
Search for other papers by Carlo Piccinni in
Google Scholar
PubMed
Search for other papers by Antonella Pedrini in
Google Scholar
PubMed
paediatric population, the fact remains that the adverse effects of therapy with levothyroxine in this special population are not known ( 28 , 29 ). In this scenario, it becomes essential to provide real-world evidence on SH in paediatric population
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Mubashir Mulla in
Google Scholar
PubMed
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Klaus-Martin Schulte in
Google Scholar
PubMed
exclude LN metastasis is based on factual evidence. For this purpose, we have tabled the actual data reported by the authors and have analysed whether their use of the terms ‘sensitivity’ and ‘negative predictive value’ (NPV) conforms to textbook
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
spermatozoa. Possibly, and perhaps even likely, prostate cancer cells utilize the same process for growth and progression to an incurable disease, but in healthy men, we do not find evidence for this to be the situation. The response of inhibin B levels to
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Britt J van Keulen in
Google Scholar
PubMed
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Michelle Romijn in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Marita de Waard in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Johannes B van Goudoever in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Reproduction & Development Research Institute, de Boelelaan, Amsterdam, The Netherlands
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
disadvantage after preterm birth ( 13 ). Although sex differences in HPA axis activity have been postulated to emerge during puberty, recent evidence suggests that such differences are already present early in life ( 14 , 15 ). However, little is known about
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Hongyun Ma in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Wenchuan Wu in
Google Scholar
PubMed
Search for other papers by Bin Song in
Google Scholar
PubMed
Search for other papers by Gang Li in
Google Scholar
PubMed
Search for other papers by Gang Jin in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
is believed that tumor grade may reflect inherent tumor aggressiveness. However, emerging evidence suggests that the 2010 WHO G3 category may not sufficiently distinguish highly proliferative WD-pNETs from PD-pNECs due to the lack of well
Search for other papers by Masatada Watanabe in
Google Scholar
PubMed
Search for other papers by Shuji Ohno in
Google Scholar
PubMed
Search for other papers by Hiroshi Wachi in
Google Scholar
PubMed
. Evidence-Based Complementary and Alternative Medicine 2015 2015 1 – 10 . ( doi:10.1155/2015/439258 ) 17 Shozu M Zhao Y Simpson ER. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene
Search for other papers by Fabian Eichelmann in
Google Scholar
PubMed
Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany
Search for other papers by Cornelia Weikert in
Google Scholar
PubMed
Search for other papers by Romina di Giuseppe in
Google Scholar
PubMed
Search for other papers by Ronald Biemann in
Google Scholar
PubMed
Search for other papers by Berend Isermann in
Google Scholar
PubMed
German Center of Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Matthias B Schulze in
Google Scholar
PubMed
Search for other papers by Heiner Boeing in
Google Scholar
PubMed
Search for other papers by Krasimira Aleksandrova in
Google Scholar
PubMed
biomarkers essentially add to the growing body of evidence implicating chemerin as a biomarker linking immunity and metabolism in relation to chronic disease risk and point to pathways implicated in adipokine production beyond adiposity per se . Our study
Search for other papers by Behnaz Abiri in
Google Scholar
PubMed
Search for other papers by Majid Valizadeh in
Google Scholar
PubMed
Search for other papers by Amirhossein Ramezani Ahmadi in
Google Scholar
PubMed
Search for other papers by Shirin Amini in
Google Scholar
PubMed
Search for other papers by Mohammad Nikoohemmat in
Google Scholar
PubMed
Search for other papers by Faeze Abbaspour in
Google Scholar
PubMed
Search for other papers by Farhad Hosseinpanah in
Google Scholar
PubMed
)D elevation. Therefore, there is contradictory evidence regarding this issue, and the accurate relationship between vitamin D and adiposity indicators remains unclear. According to the results of the studies included in the systematic review, overweight and
Search for other papers by Vittorio Unfer in
Google Scholar
PubMed
Search for other papers by Fabio Facchinetti in
Google Scholar
PubMed
Search for other papers by Beatrice Orrù in
Google Scholar
PubMed
Search for other papers by Barbara Giordani in
Google Scholar
PubMed
Search for other papers by John Nestler in
Google Scholar
PubMed
.001). Evidence of an MI effect was also identified for the HOMA index which decreased with treatment in the MI group compared to controls (SMD = −0.585, 95% CI: −1.145 to −0.025, P = 0.041) ( Fig. 3 ). Again, high heterogeneity across studies was found ( Q
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Anna C van der Burgh in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Samer R Khan in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Ewout J Hoorn in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Layal Chaker in
Google Scholar
PubMed
% CI: 0.90–0.99, Fig. 2A ) and without evidence of heterogeneity (I 2 of 0%, P -value = 0.49). Figure 2 Forest plots of serum testosterone and all-cause mortality. (A) Association of continuous serum testosterone with all-cause mortality. (B